NO20091267L - Sammensetninger og fremgangsmåter for å forebygge kreft med cupredoxiner - Google Patents

Sammensetninger og fremgangsmåter for å forebygge kreft med cupredoxiner

Info

Publication number
NO20091267L
NO20091267L NO20091267A NO20091267A NO20091267L NO 20091267 L NO20091267 L NO 20091267L NO 20091267 A NO20091267 A NO 20091267A NO 20091267 A NO20091267 A NO 20091267A NO 20091267 L NO20091267 L NO 20091267L
Authority
NO
Norway
Prior art keywords
cupredoxins
compositions
methods
prevent cancer
cancer
Prior art date
Application number
NO20091267A
Other languages
English (en)
Norwegian (no)
Inventor
Ananda Chakrabarty
Tapas Das Gupta
Original Assignee
Univ Illinois
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Illinois filed Critical Univ Illinois
Publication of NO20091267L publication Critical patent/NO20091267L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/104—Pseudomonadales, e.g. Pseudomonas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
NO20091267A 2006-09-14 2009-03-26 Sammensetninger og fremgangsmåter for å forebygge kreft med cupredoxiner NO20091267L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84435806P 2006-09-14 2006-09-14
PCT/US2007/078371 WO2008033987A2 (en) 2006-09-14 2007-09-13 Compositions and methods to prevent cancer with cupredoxins

Publications (1)

Publication Number Publication Date
NO20091267L true NO20091267L (no) 2009-06-04

Family

ID=39184582

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20091267A NO20091267L (no) 2006-09-14 2009-03-26 Sammensetninger og fremgangsmåter for å forebygge kreft med cupredoxiner

Country Status (13)

Country Link
EP (1) EP2061498A4 (enExample)
JP (2) JP2010503409A (enExample)
KR (1) KR20090059152A (enExample)
CN (1) CN101595124A (enExample)
AU (1) AU2007296429A1 (enExample)
BR (1) BRPI0714987A2 (enExample)
CA (1) CA2663498A1 (enExample)
IL (1) IL197602A0 (enExample)
MX (1) MX2009002787A (enExample)
NO (1) NO20091267L (enExample)
RU (1) RU2009113812A (enExample)
SG (1) SG174784A1 (enExample)
WO (1) WO2008033987A2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9096663B2 (en) 2001-02-15 2015-08-04 The Board Of Trustees Of The University Of Illinois Compositions and methods for treating conditions related to ephrin signaling with cupredoxins and mutants thereof
US7556810B2 (en) 2005-07-19 2009-07-07 The Board Of Trustees Of The University Of Ilinois Compositions and methods to control angiogenesis with cupredoxins
US7381701B2 (en) 2001-02-15 2008-06-03 The Borad Of Trustees Of The University Of Illinois Compositions and methods for treating conditions related to ephrin signaling with cupredoxins
US9968685B2 (en) 2004-10-07 2018-05-15 Brad N. Taylor Methods to treat cancer with cupredoxins
US10675326B2 (en) 2004-10-07 2020-06-09 The Board Of Trustees Of The University Of Illinois Compositions comprising cupredoxins for treating cancer
UA97466C2 (ru) 2004-10-07 2012-02-27 Ананда Чакрабарти Транспортирующие соединения - производные купредоксина и способы их применения
US8232244B2 (en) 2007-02-08 2012-07-31 The Board Of Trustees Of The University Of Illinois Compositions and methods to prevent cancer with cupredoxins
US9434770B2 (en) 2004-10-07 2016-09-06 Tapas K Das Gupta Modified cupredoxin derived peptides
US9598470B2 (en) * 2004-10-07 2017-03-21 Craig W. Beattie Compositions and methods to prevent cancer by stabilizing P53 through non MDM2-mediated pathways
EP1904642A4 (en) 2005-07-19 2008-11-26 Univ Illinois TRANSPORT AGENTS FOR CROSS-BREAKING BLOOD-BRAIN DISEASE AND INTRUSION IN BRAIN CANCER CELLS AND METHOD OF USE THEREOF
AU2007329375A1 (en) 2006-12-04 2008-06-12 The Board Of Trustees Of The University Of Illinois Compositions and methods to treat cancer with cupredoxins and CpG rich DNA
CA3075836A1 (en) * 2017-09-29 2019-04-04 Oncgnostics Gmbh Risk determination for neoplasia and cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7491394B2 (en) * 2001-02-15 2009-02-17 The Board Of Trustees Of The University Of Illinois Cytotoxic factors for modulating cell death
CN1506375A (zh) * 2002-12-12 2004-06-23 浙江养生堂天然药物研究所有限公司 具有广谱抗肿瘤作用的细菌蛋白天青蛋白及其用途和含有其的药物组合物
UA97466C2 (ru) * 2004-10-07 2012-02-27 Ананда Чакрабарти Транспортирующие соединения - производные купредоксина и способы их применения
AU2006277009A1 (en) * 2005-05-20 2007-02-15 The Board Of Trustees Of The University Of Illinois Compositions and methods for treating conditions related to ephrin signaling with cupredoxins
WO2007024368A2 (en) * 2005-07-19 2007-03-01 The Board Of Trustees Of The University Of Illinois Compositions and methods to control angiogenesis with cupredoxins

Also Published As

Publication number Publication date
JP2010503409A (ja) 2010-02-04
WO2008033987A3 (en) 2009-04-30
AU2007296429A1 (en) 2008-03-20
CN101595124A (zh) 2009-12-02
SG174784A1 (en) 2011-10-28
KR20090059152A (ko) 2009-06-10
JP2014050390A (ja) 2014-03-20
MX2009002787A (es) 2009-08-27
CA2663498A1 (en) 2008-03-20
IL197602A0 (en) 2011-08-01
RU2009113812A (ru) 2010-10-20
WO2008033987A2 (en) 2008-03-20
EP2061498A2 (en) 2009-05-27
EP2061498A4 (en) 2009-11-04
BRPI0714987A2 (pt) 2013-07-30

Similar Documents

Publication Publication Date Title
NO20200775A1 (no) Fremgangsmåter og sammensetninger for behandling av kreft
CR10667A (es) Compositions and methods for diagnosing and treating cancer
DK2063907T3 (da) Fremgangsmåder og sammensætninger baseret på difteritoksin-interleukin-3-konjugater
BRPI0716325A2 (pt) Composição antimicrobianas
SMAP200900058A (it) Composti e composizioni come inibitori di proteinachinasi
SM201000108B (it) Composti e composizioni come inibitori di proteinachinasi
SMAP200900020A (it) Composti e composizioni come inibitori di proteinachinasi
SMAP200900031A (it) Composti e composizioni come inibitori di proteinachinasi
EP2041267A4 (en) COMPOSITIONS AND METHODS FOR INCREASING THE USE OF GLYCEROL
DK2185164T3 (da) Sammensætning og terapeutisk antitumorvaccine
DK1984009T3 (da) Farmaceutiske sammensætninger med forbedret stabilitet
DK3263589T5 (da) Peptidsekvenser og sammensætninger
PL2356462T3 (pl) Kompozycje anty-CXCR1 oraz sposoby
EP2043136A4 (en) FILMING COMPOSITION
IL200251A0 (en) Compositions and methods to prevent cancer with cupredoxins
DK3363857T3 (da) Hybride modstandsreducerende sammensætninger med højt polymerindhold
DK2373293T3 (da) Sammensætninger med reduceret dimerdannelse
FR2899479B1 (fr) Composition cicatrisante
BRPI0905715A2 (pt) Composição farmacêutica e kit de componentes
IL197602A0 (en) Compositions and methods to prevent cancer with cupredoxins
NO20081287A (no) Brenselsammensetning og fremgangsmåte for å fremstille denne
EP2034004A4 (en) GAS OIL COMPOSITION
IL187138A0 (en) Compositions and methods for treating conditions related to ephrin signaling with cupredoxins
BRPI0812932A2 (pt) Composições e métodos de tratar câncer
DK2152699T3 (da) Quinolon-forbindelse og farmaceutisk sammensætning

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application